Protara Therapeutics (TARA) Institutional Ownership $3.11 +0.01 (+0.32%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$3.10 -0.01 (-0.32%) As of 08/22/2025 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Protara Therapeutics (NASDAQ:TARA)CurrentInstitutional OwnershipPercentage38.13%Number ofInstitutional Buyers(last 12 months)40TotalInstitutional Inflows(last 12 months)$105.46MNumber ofInstitutional Sellers(last 12 months)14TotalInstitutional Outflows(last 12 months)$9.97M Get TARA Insider Trade Alerts Want to know when executives and insiders are buying or selling Protara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TARA Institutional Buying and Selling by Quarter Protara Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Opaleye Management Inc.855,000$2.59M0.5%-50.6%2.216% 8/15/2025 Bridgeway Capital Management LLC59,830$181K0.0%+49.6%0.155% 8/15/2025 Bank of America Corp DE181,600$550K0.0%-37.1%0.471% 8/15/2025 Acorn Capital Advisors LLC1,752,115$5.31M3.5%+36.9%4.542% 8/15/2025 Adage Capital Partners GP L.L.C.400,000$1.21M0.0%N/A1.037% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.17,635$53K0.0%N/A0.046% 8/14/2025 Stempoint Capital LP1,143,677$3.47M1.1%-3.9%2.964% 8/14/2025 Velan Capital Investment Management LP2,139,000$6.48M6.4%+28.3%5.544% 8/13/2025 Marshall Wace LLP362,526$1.10M0.0%N/A0.940% 8/13/2025 Walleye Capital LLC161,091$488K0.0%-29.8%0.418% Get the Latest News and Ratings for TARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/13/2025 Invesco Ltd.23,935$73K0.0%N/A0.062% 8/13/2025 New York State Common Retirement Fund33,600$102K0.0%N/A0.087% 8/13/2025 Quadrature Capital Ltd11,591$35K0.0%N/A0.030% 8/12/2025 American Century Companies Inc.61,554$187K0.0%+69.8%0.160% 8/12/2025 JPMorgan Chase & Co.15,264$46K0.0%N/A0.040% 8/8/2025 Intech Investment Management LLC16,111$49K0.0%N/A0.042% 8/8/2025 Police & Firemen s Retirement System of New Jersey9,921$30K0.0%N/A0.026% 8/8/2025 Geode Capital Management LLC744,519$2.26M0.0%+114.7%1.930% 8/7/2025 Los Angeles Capital Management LLC15,545$47K0.0%N/A0.040% 6/27/2025 Goldman Sachs Group Inc.199,254$849K0.0%-2.0%0.516% 5/16/2025 Goldman Sachs Group Inc.199,254$849K0.0%-2.0%0.516% 5/15/2025 Velan Capital Investment Management LP1,667,800$7.11M7.3%+5.6%4.323% 5/15/2025 Driehaus Capital Management LLC272,342$1.16M0.0%-47.3%0.706% 5/15/2025 OMERS ADMINISTRATION Corp75,100$320K0.0%N/A0.195% 5/14/2025 Walleye Capital LLC229,454$977K0.0%+3.9%0.595% 5/13/2025 American Century Companies Inc.36,249$154K0.0%N/A0.094% 5/9/2025 Charles Schwab Investment Management Inc.15,000$64K0.0%N/A0.039% 4/23/2025 Oppenheimer & Co. Inc.186,564$795K0.0%-7.4%0.507% 2/19/2025 Toronto Dominion Bank2,088,937$11.03M0.0%N/A10.126% 2/17/2025 Velan Capital Investment Management LP1,579,000$8.34M7.2%+175.1%7.654% 2/17/2025 Squarepoint Ops LLC20,755$110K0.0%N/A0.101% 2/17/2025 Two Sigma Investments LP13,633$72K0.0%-92.6%0.066% 2/17/2025 Toronto Dominion Bank2,088,937$11.03M0.0%N/A10.126% 2/17/2025 Stempoint Capital LP332,394$1.76M0.4%-64.7%1.611% 2/17/2025 Millennium Management LLC371,453$1.96M0.0%+2,479.2%1.801% 2/17/2025 Integral Health Asset Management LLC1,400,000$7.39M0.6%N/A6.786% 2/17/2025 J. Goldman & Co LP141,748$748K0.0%N/A0.687% 2/17/2025 Janus Henderson Group PLC2,271,832$11.94M0.0%N/A11.012% 2/17/2025 Driehaus Capital Management LLC517,152$2.73M0.0%N/A2.507% 2/17/2025 Bridgeway Capital Management LLC25,000$132K0.0%-49.2%0.121% REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!). Click here for the names of our three top stocks to own this year (no purchase necessary).2/17/2025 Blackstone Inc.1,680,000$8.87M0.0%N/A8.143% 2/17/2025 Bank of America Corp DE194,397$1.03M0.0%+53,013.9%0.942% 2/17/2025 BNP Paribas Financial Markets151,906$802K0.0%N/A0.736% 2/17/2025 5AM Venture Management LLC800,000$4.22M1.0%N/A3.878% 2/17/2025 683 Capital Management LLC62,429$330K0.0%N/A0.303% 2/17/2025 Acorn Capital Advisors LLC1,279,800$6.76M3.7%N/A6.204% 2/14/2025 RA Capital Management L.P.3,400,000$17.95M0.2%+78.9%16.481% 2/14/2025 Boothbay Fund Management LLC88,941$470K0.0%+411.2%0.431% 2/14/2025 HBK Investments L P20,000$106K0.0%N/A0.097% 2/14/2025 Adage Capital Partners GP L.L.C.2,250,000$11.88M0.0%N/A10.906% 2/14/2025 Dimensional Fund Advisors LP20,997$111K0.0%N/A0.102% 2/13/2025 Walleye Capital LLC220,814$1.17M0.0%N/A1.070% 2/13/2025 XTX Topco Ltd11,740$62K0.0%-64.1%0.057% 2/13/2025 Barclays PLC93,239$492K0.0%N/A0.452% 2/13/2025 Renaissance Technologies LLC142,300$751K0.0%-57.7%0.690% 2/13/2025 ADAR1 Capital Management LLC122,690$648K0.1%N/A0.595% 2/12/2025 Geode Capital Management LLC179,593$948K0.0%+5.6%0.871% 2/11/2025 LPL Financial LLC36,000$190K0.0%-21.7%0.175% 2/10/2025 Commonwealth Equity Services LLC37,000$195K0.0%+90.4%0.179% 2/5/2025 Bailard Inc.29,769$157K0.0%N/A0.144% 2/5/2025 Oppenheimer & Co. Inc.201,426$1.06M0.0%+12.4%0.976% 2/4/2025 Bank of New York Mellon Corp15,883$84K0.0%-11.3%0.077% 11/16/2024 Geode Capital Management LLC170,040$311K0.0%+21.0%0.824% 11/15/2024 XTX Topco Ltd32,682$60K0.0%N/A0.158% 11/15/2024 Ikarian Capital LLC155,712$285K0.0%-13.8%0.755% 11/6/2024 Oppenheimer & Co. Inc.179,125$328K0.0%+40.8%0.868% 8/15/2024CVI Holdings LLC302,746$630K0.6%N/A1.468% 8/15/2024 Armistice Capital LLC520,000$1.08M0.0%N/A2.521% 8/14/2024 Marshall Wace LLP77,351$161K0.0%N/A0.375% 8/9/2024 Renaissance Technologies LLC150,400$313K0.0%+77.8%0.730% 8/2/2024 Privium Fund Management UK Ltd114,708$233K0.1%-4.2%0.557% 5/17/2024 Ikarian Capital LLC202,701$813K0.1%+7.4%0.984% 5/7/2024 Oppenheimer & Co. Inc.10,000$40K0.0%N/A0.087% 11/6/2023 Assenagon Asset Management S.A.15,831$26K0.0%-45.5%0.140% 7/26/2023 Privium Fund Management B.V.119,730$272K0.1%N/A1.059% 7/25/2023 Assenagon Asset Management S.A.29,051$69K0.0%+67.6%0.257% 2/10/2023 Opaleye Management Inc.2,692,594$7.22M2.5%-0.6%23.892% 2/9/2023 Privium Fund Management UK Ltd119,730$321K0.2%+242.1%1.062% 1/12/2023 Assenagon Asset Management S.A.17,336$46K0.0%-70.3%0.154% 11/14/2022 Boothbay Fund Management LLC18,864$56K0.0%-26.5%0.167% 11/1/2022 Privium Fund Management UK Ltd35,000$104K0.1%N/A0.311% 8/15/2022 Opaleye Management Inc.2,684,167$8.89M4.0%+0.4%23.823% 8/12/2022 Ikarian Capital LLC257,853$756K0.1%-13.0%2.292% 8/12/2022 DLD Asset Management LP157,349$461K0.0%-31.4%1.396% 7/27/2022 Assenagon Asset Management S.A.58,389$171K0.0%+33.5%0.519% 4/25/2022 Assenagon Asset Management S.A.43,741$224K0.0%N/A0.389% 2/22/2022 DLD Asset Management LP229,231$1.55M0.1%N/A2.040% 2/15/2022 Sender Co & Partners Inc.28,502$192K0.1%N/A0.254% 2/15/2022 DLD Asset Management LP229,231$1.55M0.1%N/A2.040% 2/14/2022 Opaleye Management Inc.2,650,000$18.00M3.8%+3.6%23.585% The Coin That Could Define Trump’s Crypto Presidency (Ad)When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”Discover the coin that could define Trump’s crypto presidency.2/10/2022 Acadian Asset Management LLC17,219$115K0.0%N/A0.153% 11/16/2021 Two Sigma Advisers LP168,818$1.17M0.0%+189.5%1.502% 11/16/2021 Two Sigma Investments LP130,935$906K0.0%+136.3%1.165% 11/15/2021 Marshall Wace LLP15,190$105K0.0%-13.0%0.135% 11/12/2021 Trexquant Investment LP12,454$86K0.0%N/A0.111% 11/12/2021 Renaissance Technologies LLC115,900$802K0.0%+125.4%1.032% 11/12/2021 Jump Financial LLC14,500$100K0.0%N/A0.129% 11/10/2021 Goldman Sachs Group Inc.155,973$1.08M0.0%+17.9%1.388% 11/9/2021BlackRock Inc.44,036$306K0.0%+9.7%0.392% 8/25/2021 Marshall Wace LLP17,469$170K0.0%-58.5%0.155% (Data available from 1/1/2016 forward) TARA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TARA shares? During the previous two years, 52 institutional investors and hedge funds held shares of Protara Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($17.95M), Janus Henderson Group PLC ($11.94M), Toronto Dominion Bank ($11.03M), Blackstone Inc. ($8.87M), Integral Health Asset Management LLC ($7.39M), Velan Capital Investment Management LP ($6.48M), and Acorn Capital Advisors LLC ($5.31M).Learn more on Protara Therapeutics' institutional investors. What percentage of Protara Therapeutics' stock is owned by institutional investors? 38.13% of Protara Therapeutics' stock is owned by institutional investors. Learn more on TARA's institutional investor holdings. Which institutional investors have been buying Protara Therapeutics' stock? Of the 44 institutional investors that purchased Protara Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Toronto Dominion Bank ($4.18M), Adage Capital Partners GP L.L.C. ($2.65M), Janus Henderson Group PLC ($2.27M), Acorn Capital Advisors LLC ($1.75M), Blackstone Inc. ($1.68M), Velan Capital Investment Management LP ($1.57M), and RA Capital Management L.P. ($1.50M). How much institutional buying is happening at Protara Therapeutics? Institutional investors have bought a total of 21,068,585 shares in the last 24 months. This purchase volume represents approximately $105.46M in transactions. Which of Protara Therapeutics' major shareholders have been selling company stock? Of the 14 institutional investors that sold Protara Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Opaleye Management Inc. ($875K), Stempoint Capital LP ($657.37K), Driehaus Capital Management LLC ($244.81K), Renaissance Technologies LLC ($194.44K), Two Sigma Investments LP ($171.59K), Bank of America Corp DE ($107.12K), and Walleye Capital LLC ($68.36K). How much institutional selling is happening at Protara Therapeutics? Institutional investors have sold a total of 2,423,655 shares in the last 24 months. This volume of shares sold represents approximately $9.97M in transactions. Related Companies ERAS Major Shareholders ETON Major Shareholders CGEM Major Shareholders TNXP Major Shareholders ITOS Major Shareholders GOSS Major Shareholders RGNX Major Shareholders PRTA Major Shareholders TECX Major Shareholders EOLS Major Shareholders This page (NASDAQ:TARA) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access